Overview

osM


'osM' can also refer to...

OS&M

osM

OS-OFFERMANS, M. van - Painter

OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas

OS1.4 Current treatment regimens induce the mTORC1 inhibitor REDD1 in human glioblastoma cells: implications for treatment efficacy

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) – a validation study

908PAssociation between biopsychosocial distress (BPSD) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

268PWhat are the treatment patterns and overall survival (OS) in patients with metastatic triple-negative breast cancer (mTNBC) in US clinical practice?

267PCan contemporary trials in HER2-negative metastatic breast cancer (mBC) detect overall survival (OS) benefit?

P-149Impact of sequence of biologic therapies on overall survival (OS) in patients with RAS wild-type (WT) metastatic colorectal carcinoma (mCRC): an exploratory, retrospective pooled analysis

The Epidemiology of Schizophrenia. Murray RM, Jones PB, Susser E, Van Os J, Cannon M (eds). Cambridge: Cambridge University Press, 2002, pp. 470, £55.00 ISBN: 0-521-77540-X.

ES and OsM v City of Prague, Cassation complaint, 8 As 51/2007-67, ILDC 992 (CZ 2007), 5th November 2007, Czech Republic [cz]

Is baseline neutrophil to lymphocyte ratio (NLR) an independent prognostic biomarker for progression free survival (PFS) and overall survival (OS) in metastatic colorectal cancer (mCRC)? Analysis of the AGITG MAX study

genitourinary tumours, prostateFinal overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel/prednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC)

P-328Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - An analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie

Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

1348POverall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies

B8Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

or

symbol for osmolar (osmol L−1 now recommended).

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.